Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Shortly after, in 1949, Doctor Phillip Flynn joined Doctor Pelphrey’s practice.
Upon the recommendation of Boone Powell, executive director, a special committee of the Baylor University Hospital board was appointed in mid 1958 to consider the future relationship between the hospital and the Wadley Blood Institute.
When Doctor George Race came to Baylor in September 1959, <100 people were employed in the laboratories, and most tests had to be performed by hand.
The laboratory began to change when Doctor Race became director in 1959.
By January 1, 1960, the staff included 6 pathologists: Drs.
Doctor Kingsley joined that partnership when he arrived in 1961; he had been recruited through an advertisement in a national journal.
The first upgrading of the laboratory space occurred with a remodeling of the third, fourth, and fifth floors of the Y-wing in 1961.
Doctor Norman Helgeson, who had a special interest in microbiology, joined the BUMC medical staff in 1966 from the Massachusetts General Hospital.
Doctor George Race (left) with Doctor Dighton Rowan, director of virology, and Doctor Floyd Norman, chief of pediatrics, in 1968.
Doctor Doris Vendrell joined the staff in 1970 and became director of the autopsy service.
Clinical Labs of Hawaii (CLH) and Pan Pacific Pathologists were founded in 1971, by Doctor Moon S. Park.
With the addition in 1972 of Doctor Alain Marengo-Rowe from Oxford, a special hematology laboratory, blood bank, and coagulation unit were established.
The Plaza Reference Laboratory was established at BUMC in 1974 as a taxable enterprise owned by BHCS. William S. Carter, executive vice president of BHCS, served as president of the corporation.
Doctor Charles Rietz joined the surgical pathology staff in 1975.
Medicare-Medicaid Fraud and Abuse Amendments were adopted in 1977.
A nephrology laboratory was introduced in 1978 when Doctor Martin White was appointed director of nephrology for the institution.
Doctor James J. Aguanno, a PhD from Memphis State University, joined the clinical chemistry staff in 1980.
The Tax Equity and Fiscal Responsibility Act, adopted in 1982, brought laboratories along with other units of hospitals under reimbursement limits.
In 1985, the final revision of Laboratory Medicine was published and has long continued in use across the nation.
Doctor Marengo-Rowe recalled that in 1985, the transfusion service moved to a new location on the second floor of Roberts Hospital.
In 1986, a major change was made in the direction and administration of the BUMC laboratories.
Since its establishment in 1987, Sonic Healthcare has grown to become the world’s third largest pathology/laboratory medicine company with operations in eight countries.
In about 1987, therefore, it was considered essential by BHCS's pathologists that a major effort be made to select and obtain a laboratory information system that could provide the massive amounts of data processing and control capacity needed by BUMC's laboratories.
In 1988, upon the retirement of Doctor William B. Kingsley, Doctor Savino became director of surgical pathology.
In 1989, Doctor William G. Herlihy assumed the directorship of the autopsy service after the retirement of Doctor Vendrell.
With the deterioration of service levels, the partnership was dissolved in 1989.
Increased surgical volume was provided for in July 1990 by building a satellite laboratory in the new Roberts Hospital building to supply “stat” testing in hemostasis, hematology, and clinical chemistry.
Testing introduced in 1990, along with stricter selection of donors, reduced successfully the incidence of post-transfusion hepatitis from 1 in 200 to <1 in 100,000.
In the following year, the Omnibus Budget Reconciliation Act of 1990 reduced laboratory fee schedules again and barred self referral to laboratories owned by physicians.
In 1997, however, much of the testing was changed to polymerase chain reactions to improve and expand the scope of tissue typing and organ matching, The newer technology allowed for better, broader-based tissue typing, which improved organ and patient survival.
In 2000, BUMC had 18 approved pathology resident trainee positions.
In 2008 Clinical Labs of Hawaii became a member of Sonic Healthcare Ltd.
Starting in 2010, the expansion added 30,000 square feet of space originally intended for laboratory and administrative functions.
In 2016, SRL adopts the latest next generation sequencing (NGS) platforms.
On May 1st, 2018, CPL celebrated 70 years serving the medical community and offering the highest quality laboratory services dedicated to the individual needs of health care providers and their patients.
Rate how well Clinical Pathology Laboratories lives up to its initial vision.
Do you work at Clinical Pathology Laboratories?
Is Clinical Pathology Laboratories' vision a big part of strategic planning?
| Company name | Founded date | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Laboratory Corporation of America Holdings | 1978 | $13.0B | 72,000 | 2,283 |
| Sunrise Medical Laboratories | - | $46.0M | 310 | - |
| Quest Diagnostics | 1967 | $9.9B | 47,000 | 2,841 |
| BioReference Laboratories | 1981 | - | 5,000 | - |
| Sonora Quest Labs | 1997 | $170.0M | 1,040 | 82 |
| Solstas Lab Partners Group, LLC | 1997 | $270.0M | 3,000 | - |
| Clinical Laboratory Partners | 1998 | $52.0M | 500 | - |
| Community Blood Center | 1995 | $50.0M | 64 | 18 |
| American Health Associates, Inc. | 1990 | $6.5M | 50 | 102 |
| Oklahoma Blood Institute | 1977 | $100.0M | 680 | 21 |
Zippia gives an in-depth look into the details of Clinical Pathology Laboratories, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Clinical Pathology Laboratories. The employee data is based on information from people who have self-reported their past or current employments at Clinical Pathology Laboratories. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Clinical Pathology Laboratories. The data presented on this page does not represent the view of Clinical Pathology Laboratories and its employees or that of Zippia.
Clinical Pathology Laboratories may also be known as or be related to Clinical Pathology Laboratories, Clinical Pathology Laboratories Inc, Clinical Pathology Laboratories, ... and Clinical Pathology Laboratories, Inc.